4

MAIN DOCUMENT DESCRIPTION

Company: Protalix BioTherapeutics, Inc.
Filed: August 9, 2010
Period of Report: August 5, 2010
Accession Number: 0001209191-10-041740

View Document ↗ View on SEC.gov ↗